Quarterly report pursuant to Section 13 or 15(d)

SEGMENTS (Tables)

v3.21.2
SEGMENTS (Tables)
9 Months Ended
Sep. 30, 2021
SEGMENTS [Abstract]  
Summarized Financial Information Concerning Reportable Segments Summarized financial information concerning reportable segments is shown in the following tables:

Three Months Ended September 30, 2021
 
   
ADMA
BioManufacturing
   
Plasma Collection
Centers
   
Corporate
   
Consolidated
 
                         
Revenues
 
$
19,063,077
   
$
1,581,765
   
$
35,708
   
$
20,680,550
 
                                 
Cost of product revenue
   
18,695,783
     
1,599,430
     
-
     
20,295,213
 
                                 
Loss from operations
   
(7,456,129
)
   
(3,163,886
)
   
(3,817,061
)
   
(14,437,076
)
                                 
Interest and other income (expense), net
   
22,822
   
(1,597
)
   
(3,297,103
)
   
(3,275,878
)
                                 
Net loss
   
(7,433,307
)
   
(3,165,483
)
   
(7,114,164
)
   
(17,712,954
)
                                 
Depreciation and amortization expense
   
1,064,757
     
356,233
     
1,174
     
1,422,164
 
Total assets
   
189,019,883
     
22,273,264
     
27,347,259
     
238,640,406
 

Three Months Ended September 30, 2020
 
   
ADMA
BioManufacturing
   
Plasma Collection
Centers
   
Corporate
   
Consolidated
 
                         
Revenues
 
$
9,026,323
   
$
1,214,327
   
$
35,708
   
$
10,276,358
 
                                 
Cost of product revenue
   
10,625,837
     
1,229,627
     
-
     
11,855,464
 
                                 
Loss from operations
   
(9,277,702
)
   
(1,320,461
)
   
(3,202,814
)
   
(13,800,977
)
                                 
Interest and other expense, net
   
(268,023
)
   
(411
)
   
(2,848,042
)
   
(3,116,476
)
                                 
Net loss
   
(9,545,725
)
   
(1,320,872
)
   
(6,050,856
)
   
(16,917,453
)
                                 
Depreciation and amortization expense
   
863,366
     
169,691
     
2,236
     
1,035,293
 
Total assets
   
125,004,813
     
9,358,823
     
55,612,407
     
189,976,043
 

Nine Months Ended September 30, 2021
 
   
ADMA
BioManufacturing
   
Plasma Collection
Centers
   
Corporate
   
Consolidated
 
                         
Revenues
 
$
48,832,000
   
$
5,620,633
   
$
107,125
   
$
54,559,758
 
                                 
Cost of product revenue
   
51,527,832
     
5,370,127
     
-
     
56,897,959
 
                                 
Loss from operations
   
(25,299,223
)
   
(7,928,946
)
   
(11,954,388
)
   
(45,182,557
)
                                 
Interest and other expense, net
   
(77,484
)
   
(2,349
)
   
(9,735,808
)
   
(9,815,641
)
                                 
Net loss
   
(25,376,707
)
   
(7,931,295
)
   
(21,690,196
)
   
(54,998,198
)
                                 
Capital expenditures
   
3,805,472
     
6,029,932
     
-
     
9,835,404
 
Depreciation and amortization expense
   
3,130,064
     
843,151
     
4,571
     
3,977,786
 

Nine Months Ended September 30, 2020
 
   
ADMA
BioManufacturing
   
Plasma Collection
Centers
   
Corporate
   
Consolidated
 
                         
Revenues
 
$
23,272,463
   
$
4,884,108
   
$
107,125
   
$
28,263,696
 
                                 
Cost of product revenue
   
37,314,930
     
4,865,389
     
-
     
42,180,319
 
                                 
Loss from operations
   
(34,606,679
)
   
(2,696,927
)
   
(10,390,982
)
   
(47,694,588
)
                                 
Interest and other expense, net
   
(742,336
)
   
(444
)
   
(7,903,406
)
   
(8,646,186
)
                                 
Net loss
   
(35,349,015
)
   
(2,697,371
)
   
(18,294,388
)
   
(56,340,774
)
                                 
Capital expenditures
   
6,619,399
     
2,508,960
     
-
     
9,128,359
 
Depreciation and amortization expense
   
2,310,580
     
392,086
     
7,117
     
2,709,783
 
Net Revenues According to Geographic Area
Net revenues according to geographic area, based on the location of where the product is shipped, is as follows:

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2021
   
2020
   
2021
   
2020
 
United States
 
$
18,265,945
   
$
8,809,667
   
$
47,368,793
   
$
24,263,110
 
International
   
2,414,605
     
1,466,691
     
7,190,965
     
4,000,586
 
Total revenues
 
$
20,680,550
   
$
10,276,358
   
$
54,559,758
   
$
28,263,696